Cargando…

Prediction of Future Medical Costs by Modifiable Measures of Health

INTRODUCTION: Strategies to mitigate rising health-care costs are a priority for patients, employers, and health insurers. Yet gaps currently exist in whether health risk assessment can forecast medical claims costs. This study examined the ability of a health quotient (HQ) based on modifiable risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haji-Sheikhi, Farnoosh, Fragala, Maren S, Bare, Lance A, Rowland, Charles M, Goldberg, Steven E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319160/ https://www.ncbi.nlm.nih.gov/pubmed/37408662 http://dx.doi.org/10.2147/CEOR.S406525

Ejemplares similares

Cardiometabolic Risk Increased in Working-Aged Adults During the COVID-19 Pandemic
por: Fragala, Maren S., et al.
Publicado: (2023)

Self-Insured Employer Health Benefits Strategy Established a Negative Cost Trend While Improving Performance
por: Goldberg, Steven E., et al.
Publicado: (2019)

Workplace Outreach Program Improves Management of Chronic Kidney Disease
por: Iakoubova, Olga A., et al.
Publicado: (2022)

Return to Work: Managing Employee Population Health During the COVID-19 Pandemic
por: Fragala, Maren S., et al.
Publicado: (2021)

Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory
por: Guy, Carrie, et al.
Publicado: (2019)

Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance
por: Plantes, Peter J., et al.
Publicado: (2021)

Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population
por: Keogh, Murray, et al.
Publicado: (2022)

Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High-Throughput Immunoassays Authorized for Emergency Use
por: Prince, Harry E., et al.
Publicado: (2020)

Association of changes in lipid levels with changes in vitamin D levels in a real-world setting
por: Li, Yonghong, et al.
Publicado: (2021)

Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis
por: Shiffman, Dov, et al.
Publicado: (2015)

Incorporating future unrelated medical costs in cost-effectiveness analysis in China
por: Jiang, Shan, et al.
Publicado: (2021)

Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma
por: Li, Yonghong, et al.
Publicado: (2015)

Trifunctional Epoxy Resin Composites Modified by Soluble Electrospun Veils: Effect on the Viscoelastic and Morphological Properties
por: Ognibene, Giulia, et al.
Publicado: (2018)

Assessing the impact of a comprehensive mental health program on frontline health service workers
por: Ward, Emily J., et al.
Publicado: (2023)

Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis
por: Shiffman, Dov, et al.
Publicado: (2016)

Measurement invariance of the Depression Anxiety Stress Scales-21 across medical student genders
por: Jafari, Peyman, et al.
Publicado: (2017)

Biomarkers in Sports and Exercise: Tracking Health, Performance, and Recovery in Athletes
por: Lee, Elaine C., et al.
Publicado: (2017)

Use of an Early Disease-Modifying Drug Adherence Measure to Predict Future Adherence in Patients with Multiple Sclerosis
por: Kozma, Chris M., et al.
Publicado: (2014)

Challenges in Predicting Future Costs for Metastatic Breast Cancer
por: Dinan, Michaela A, et al.
Publicado: (2021)

Effects of 28-days ingestion of a slow-release energy supplement versus placebo on hematological and cardiovascular measures of health
por: Wells, Adam J, et al.
Publicado: (2014)

Investigation of KIF6 Trp719Arg in a Case-Control Study of Myocardial Infarction: A Costa Rican Population
por: Bare, Lance A., et al.
Publicado: (2010)

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
por: de Vries, Linda M., et al.
Publicado: (2018)

Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios
por: Goryakin, Yevgeniy, et al.
Publicado: (2020)

PES/POSS Soluble Veils as Advanced Modifiers for Multifunctional Fiber Reinforced Composites
por: Cicala, Gianluca, et al.
Publicado: (2017)

Facilitating Mental Health Treatment Through Proactive Screening and Concierge Services in the Workplace
por: Fragala, Maren S., et al.
Publicado: (2023)

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries
por: Mokri, Hamraz, et al.
Publicado: (2022)

Associations of aerobic and strength exercise with clinical laboratory test values
por: Fragala, Maren. S., et al.
Publicado: (2017)

Keep it simple? Predicting primary health care costs with clinical morbidity measures
por: Brilleman, Samuel L., et al.
Publicado: (2014)

Challenges in predicting future high-cost patients for care management interventions
por: Crowley, Chris, et al.
Publicado: (2023)

Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults
por: Li, Yonghong, et al.
Publicado: (2021)

Genetic variants in the KIF6 region and coronary event reduction from statin therapy
por: Li, Yonghong, et al.
Publicado: (2010)

Growth Hormone(s), Testosterone, Insulin-Like Growth Factors, and Cortisol: Roles and Integration for Cellular Development and Growth With Exercise
por: Kraemer, William J., et al.
Publicado: (2020)

Future costs in cost-effectiveness analysis: an empirical assessment
por: Kruse, Marie, et al.
Publicado: (2010)

Looking beyond Administrative Health Care Data: The Role of Socioeconomic Status in Predicting Future High-cost Patients with Mental Health and Addiction
por: de Oliveira, Claire, et al.
Publicado: (2021)

HEALTH DISPARITIES RELATED TO COST OF MEDICAL COVERAGE
por: Palmer, Nathaniel, et al.
Publicado: (2022)

Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring
por: Fragala, Maren S., et al.
Publicado: (2021)

Comparing the Cost-Effectiveness of Disease-Modifying Drugs for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis
por: Goldberg, Lawrence, et al.
Publicado: (2009)

Using Previous Medication Adherence to Predict Future Adherence
por: Kumamaru, Hiraku, et al.
Publicado: (2018)

Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity
por: Keim-Malpass, Jessica, et al.
Publicado: (2022)

A modified Kakwani measure for health inequality
por: Fukushige, Mototsugu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1qf010gh79l3dtb235cdp7f69p